Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients

التفاصيل البيبلوغرافية
العنوان: Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients
المؤلفون: Olaf M. Dekkers, Gerlof D. Valk, Wouter T Zandee, M. R. Vriens, Wouter W. de Herder, Bas Havekes, Mirthe J Klein Haneveld, Annenienke C van de Ven, Peter H. Bisschop, Carolina R.C. Pieterman, Madeleine L. Drent, Annemarie A Verrijn Stuart, Mark J C van Treijen, Rachel S van Leeuwaarde
المساهمون: Internal Medicine, Internal medicine, Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep, Amsterdam Gastroenterology Endocrinology Metabolism, Interne Geneeskunde, MUMC+: MA Endocrinologie (9), RS: NUTRIM - R1 - Obesity, diabetes and cardiovascular health, Endocrinology, AMS - Ageing & Vitality, AMS - Musculoskeletal Health
المصدر: Journal of Clinical Endocrinology and Metabolism, 106, 3515-3525
Journal of Clinical Endocrinology and Metabolism, 106(12), 3515-3525. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 106(12), 3515-3525. ENDOCRINE SOC
Journal of Clinical Endocrinology and Metabolism, 106(12), 3515-3525. The Endocrine Society
Journal of Clinical Endocrinology & Metabolism, 106(12), 3515-3525. Oxford University Press
Journal of Clinical Endocrinology and Metabolism, 106, 12, pp. 3515-3525
Journal of clinical endocrinology and metabolism, 106(12), 3515-3525. The Endocrine Society
Klein Haneveld, M J, van Treijen, M J C, Pieterman, C R C, Dekkers, O M, van de Ven, A, de Herder, W W, Zandee, W T, Drent, M L, Bisschop, P H, Havekes, B, Vriens, M R, Verrijn Stuart, A A, Valk, G D & van Leeuwaarde, R S 2021, ' Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients : Results from the DutchMEN Study Group ', Journal of Clinical Endocrinology and Metabolism, vol. 106, no. 12, pp. 3515-3525 . https://doi.org/10.1210/clinem/dgab569Test
سنة النشر: 2021
مصطلحات موضوعية: Oncology, Male, Databases, Factual, Endocrinology, Diabetes and Metabolism, Neuroendocrine Tumors/diagnosis, Clinical Biochemistry, Disease, Biochemistry, multiple endocrine neoplasia type 1, Endocrinology, Medicine, Age of Onset, Multiple endocrine neoplasia, Child, Early Detection of Cancer, Netherlands, ENDOCRINE NEOPLASIA TYPE-1, education.field_of_study, INTERVAL-CENSORED-DATA, Middle Aged, Prognosis, Penetrance, age-related penetrance, Tumor Burden, Survival Rate, Neuroendocrine Tumors, Child, Preschool, Cohort, surveillance, Female, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Adult, Diagnostic Imaging, medicine.medical_specialty, pancreatic NET, Adolescent, Population, Context (language use), Netherlands/epidemiology, Databases, Young Adult, SDG 3 - Good Health and Well-being, Internal medicine, Humans, MEN1, Pancreatic Neoplasms/diagnosis, education, Preschool, Survival analysis, Factual, Aged, Retrospective Studies, business.industry, Biochemistry (medical), medicine.disease, Pancreatic Neoplasms, Multiple Endocrine Neoplasia Type 1/physiopathology, Early Detection of Cancer/methods, business, Follow-Up Studies
الوصف: ContextNonfunctioning pancreatic neuroendocrine tumors (NF-pNETs) are highly prevalent and constitute an important cause of mortality in patients with multiple endocrine neoplasia type 1 (MEN1). Still, the optimal age to initiate screening for pNETs is under debate.ObjectiveThe aim of this work is to assess the age of occurrence of clinically relevant NF-pNETs in young MEN1 patients.MethodsPancreatic imaging data of MEN1 patients were retrieved from the DutchMEN Study Group database. Interval-censored survival methods were used to describe age-related penetrance, compare survival curves, and develop a parametric model for estimating the risk of having clinically relevant NF-pNET at various ages. The primary objective was to assess age at occurrence of clinically relevant NF-pNET (size ≥ 20 mm or rapid growth); secondary objectives were the age at occurrence of NF-pNET of any size and pNET-associated metastasized disease.ResultsFive of 350 patients developed clinically relevant NF-pNETs before age 18 years, 2 of whom subsequently developed lymph node metastases. No differences in clinically relevant NF-pNET–free survival were found for sex, time frame, and type of MEN1 diagnosis or genotype. The estimated ages (median, 95% CI) at a 1%, 2.5%, and 5% risk of having developed a clinically relevant tumor are 9.5 (6.5-12.7), 13.5 (10.2-16.9), and 17.8 years (14.3-21.4), respectively.ConclusionAnalyses from this population-based cohort indicate that start of surveillance for NF-pNETs with pancreatic imaging at age 13 to 14 years is justified. The psychological and medical burden of screening at a young age should be considered.
وصف الملف: application/pdf
اللغة: English
تدمد: 0021-972X
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ce36b25c25d31e1a499d42dbc31157Test
https://doi.org/10.1210/clinem/dgab569Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....b2ce36b25c25d31e1a499d42dbc31157
قاعدة البيانات: OpenAIRE
ResultId 1
Header edsair
OpenAIRE
edsair.doi.dedup.....b2ce36b25c25d31e1a499d42dbc31157
898
3

unknown
897.864318847656
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b2ce36b25c25d31e1a499d42dbc31157&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Olaf+M%2E+Dekkers%22">Olaf M. Dekkers</searchLink><br /><searchLink fieldCode="AR" term="%22Gerlof+D%2E+Valk%22">Gerlof D. Valk</searchLink><br /><searchLink fieldCode="AR" term="%22Wouter+T+Zandee%22">Wouter T Zandee</searchLink><br /><searchLink fieldCode="AR" term="%22M%2E+R%2E+Vriens%22">M. R. Vriens</searchLink><br /><searchLink fieldCode="AR" term="%22Wouter+W%2E+de+Herder%22">Wouter W. de Herder</searchLink><br /><searchLink fieldCode="AR" term="%22Bas+Havekes%22">Bas Havekes</searchLink><br /><searchLink fieldCode="AR" term="%22Mirthe+J+Klein+Haneveld%22">Mirthe J Klein Haneveld</searchLink><br /><searchLink fieldCode="AR" term="%22Annenienke+C+van+de+Ven%22">Annenienke C van de Ven</searchLink><br /><searchLink fieldCode="AR" term="%22Peter+H%2E+Bisschop%22">Peter H. Bisschop</searchLink><br /><searchLink fieldCode="AR" term="%22Carolina+R%2EC%2E+Pieterman%22">Carolina R.C. Pieterman</searchLink><br /><searchLink fieldCode="AR" term="%22Madeleine+L%2E+Drent%22">Madeleine L. Drent</searchLink><br /><searchLink fieldCode="AR" term="%22Annemarie+A+Verrijn+Stuart%22">Annemarie A Verrijn Stuart</searchLink><br /><searchLink fieldCode="AR" term="%22Mark+J+C+van+Treijen%22">Mark J C van Treijen</searchLink><br /><searchLink fieldCode="AR" term="%22Rachel+S+van+Leeuwaarde%22">Rachel S van Leeuwaarde</searchLink> )
Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => Internal Medicine<br />Internal medicine<br />Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep<br />Amsterdam Gastroenterology Endocrinology Metabolism<br />Interne Geneeskunde<br />MUMC+: MA Endocrinologie (9)<br />RS: NUTRIM - R1 - Obesity, diabetes and cardiovascular health<br />Endocrinology<br />AMS - Ageing & Vitality<br />AMS - Musculoskeletal Health )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Journal of Clinical Endocrinology and Metabolism, 106, 3515-3525<br />Journal of Clinical Endocrinology and Metabolism, 106(12), 3515-3525. Endocrine Society<br />Journal of Clinical Endocrinology and Metabolism, 106(12), 3515-3525. ENDOCRINE SOC<br />Journal of Clinical Endocrinology and Metabolism, 106(12), 3515-3525. The Endocrine Society<br />Journal of Clinical Endocrinology & Metabolism, 106(12), 3515-3525. Oxford University Press<br />Journal of Clinical Endocrinology and Metabolism, 106, 12, pp. 3515-3525<br />Journal of clinical endocrinology and metabolism, 106(12), 3515-3525. The Endocrine Society<br />Klein Haneveld, M J, van Treijen, M J C, Pieterman, C R C, Dekkers, O M, van de Ven, A, de Herder, W W, Zandee, W T, Drent, M L, Bisschop, P H, Havekes, B, Vriens, M R, Verrijn Stuart, A A, Valk, G D & van Leeuwaarde, R S 2021, ' Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients : Results from the DutchMEN Study Group ', Journal of Clinical Endocrinology and Metabolism, vol. 106, no. 12, pp. 3515-3525 . https://doi.org/10.1210/clinem/dgab569 )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2021 )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Oncology%22">Oncology</searchLink><br /><searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22Databases%2C+Factual%22">Databases, Factual</searchLink><br /><searchLink fieldCode="DE" term="%22Endocrinology%2C+Diabetes+and+Metabolism%22">Endocrinology, Diabetes and Metabolism</searchLink><br /><searchLink fieldCode="DE" term="%22Neuroendocrine+Tumors%2Fdiagnosis%22">Neuroendocrine Tumors/diagnosis</searchLink><br /><searchLink fieldCode="DE" term="%22Clinical+Biochemistry%22">Clinical Biochemistry</searchLink><br /><searchLink fieldCode="DE" term="%22Disease%22">Disease</searchLink><br /><searchLink fieldCode="DE" term="%22Biochemistry%22">Biochemistry</searchLink><br /><searchLink fieldCode="DE" term="%22multiple+endocrine+neoplasia+type+1%22">multiple endocrine neoplasia type 1</searchLink><br /><searchLink fieldCode="DE" term="%22Endocrinology%22">Endocrinology</searchLink><br /><searchLink fieldCode="DE" term="%22Medicine%22">Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Age+of+Onset%22">Age of Onset</searchLink><br /><searchLink fieldCode="DE" term="%22Multiple+endocrine+neoplasia%22">Multiple endocrine neoplasia</searchLink><br /><searchLink fieldCode="DE" term="%22Child%22">Child</searchLink><br /><searchLink fieldCode="DE" term="%22Early+Detection+of+Cancer%22">Early Detection of Cancer</searchLink><br /><searchLink fieldCode="DE" term="%22Netherlands%22">Netherlands</searchLink><br /><searchLink fieldCode="DE" term="%22ENDOCRINE+NEOPLASIA+TYPE-1%22">ENDOCRINE NEOPLASIA TYPE-1</searchLink><br /><searchLink fieldCode="DE" term="%22education%2Efield%5Fof%5Fstudy%22">education.field_of_study</searchLink><br /><searchLink fieldCode="DE" term="%22INTERVAL-CENSORED-DATA%22">INTERVAL-CENSORED-DATA</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Prognosis%22">Prognosis</searchLink><br /><searchLink fieldCode="DE" term="%22Penetrance%22">Penetrance</searchLink><br /><searchLink fieldCode="DE" term="%22age-related+penetrance%22">age-related penetrance</searchLink><br /><searchLink fieldCode="DE" term="%22Tumor+Burden%22">Tumor Burden</searchLink><br /><searchLink fieldCode="DE" term="%22Survival+Rate%22">Survival Rate</searchLink><br /><searchLink fieldCode="DE" term="%22Neuroendocrine+Tumors%22">Neuroendocrine Tumors</searchLink><br /><searchLink fieldCode="DE" term="%22Child%2C+Preschool%22">Child, Preschool</searchLink><br /><searchLink fieldCode="DE" term="%22Cohort%22">Cohort</searchLink><br /><searchLink fieldCode="DE" term="%22surveillance%22">surveillance</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22Rare+cancers+Radboud+Institute+for+Health+Sciences+[Radboudumc+9]%22">Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]</searchLink><br /><searchLink fieldCode="DE" term="%22Adult%22">Adult</searchLink><br /><searchLink fieldCode="DE" term="%22Diagnostic+Imaging%22">Diagnostic Imaging</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Fspecialty%22">medicine.medical_specialty</searchLink><br /><searchLink fieldCode="DE" term="%22pancreatic+NET%22">pancreatic NET</searchLink><br /><searchLink fieldCode="DE" term="%22Adolescent%22">Adolescent</searchLink><br /><searchLink fieldCode="DE" term="%22Population%22">Population</searchLink><br /><searchLink fieldCode="DE" term="%22Context+%28language+use%29%22">Context (language use)</searchLink><br /><searchLink fieldCode="DE" term="%22Netherlands%2Fepidemiology%22">Netherlands/epidemiology</searchLink><br /><searchLink fieldCode="DE" term="%22Databases%22">Databases</searchLink><br /><searchLink fieldCode="DE" term="%22Young+Adult%22">Young Adult</searchLink><br /><searchLink fieldCode="DE" term="%22SDG+3+-+Good+Health+and+Well-being%22">SDG 3 - Good Health and Well-being</searchLink><br /><searchLink fieldCode="DE" term="%22Internal+medicine%22">Internal medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22MEN1%22">MEN1</searchLink><br /><searchLink fieldCode="DE" term="%22Pancreatic+Neoplasms%2Fdiagnosis%22">Pancreatic Neoplasms/diagnosis</searchLink><br /><searchLink fieldCode="DE" term="%22education%22">education</searchLink><br /><searchLink fieldCode="DE" term="%22Preschool%22">Preschool</searchLink><br /><searchLink fieldCode="DE" term="%22Survival+analysis%22">Survival analysis</searchLink><br /><searchLink fieldCode="DE" term="%22Factual%22">Factual</searchLink><br /><searchLink fieldCode="DE" term="%22Aged%22">Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Retrospective+Studies%22">Retrospective Studies</searchLink><br /><searchLink fieldCode="DE" term="%22business%2Eindustry%22">business.industry</searchLink><br /><searchLink fieldCode="DE" term="%22Biochemistry+%28medical%29%22">Biochemistry (medical)</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edisease%22">medicine.disease</searchLink><br /><searchLink fieldCode="DE" term="%22Pancreatic+Neoplasms%22">Pancreatic Neoplasms</searchLink><br /><searchLink fieldCode="DE" term="%22Multiple+Endocrine+Neoplasia+Type+1%2Fphysiopathology%22">Multiple Endocrine Neoplasia Type 1/physiopathology</searchLink><br /><searchLink fieldCode="DE" term="%22Early+Detection+of+Cancer%2Fmethods%22">Early Detection of Cancer/methods</searchLink><br /><searchLink fieldCode="DE" term="%22business%22">business</searchLink><br /><searchLink fieldCode="DE" term="%22Follow-Up+Studies%22">Follow-Up Studies</searchLink> )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => ContextNonfunctioning pancreatic neuroendocrine tumors (NF-pNETs) are highly prevalent and constitute an important cause of mortality in patients with multiple endocrine neoplasia type 1 (MEN1). Still, the optimal age to initiate screening for pNETs is under debate.ObjectiveThe aim of this work is to assess the age of occurrence of clinically relevant NF-pNETs in young MEN1 patients.MethodsPancreatic imaging data of MEN1 patients were retrieved from the DutchMEN Study Group database. Interval-censored survival methods were used to describe age-related penetrance, compare survival curves, and develop a parametric model for estimating the risk of having clinically relevant NF-pNET at various ages. The primary objective was to assess age at occurrence of clinically relevant NF-pNET (size ≥ 20 mm or rapid growth); secondary objectives were the age at occurrence of NF-pNET of any size and pNET-associated metastasized disease.ResultsFive of 350 patients developed clinically relevant NF-pNETs before age 18 years, 2 of whom subsequently developed lymph node metastases. No differences in clinically relevant NF-pNET–free survival were found for sex, time frame, and type of MEN1 diagnosis or genotype. The estimated ages (median, 95% CI) at a 1%, 2.5%, and 5% risk of having developed a clinically relevant tumor are 9.5 (6.5-12.7), 13.5 (10.2-16.9), and 17.8 years (14.3-21.4), respectively.ConclusionAnalyses from this population-based cohort indicate that start of surveillance for NF-pNETs with pancreatic imaging at age 13 to 14 years is justified. The psychological and medical burden of screening at a young age should be considered. )
Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => application/pdf )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English )
Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 0021-972X )
Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ce36b25c25d31e1a499d42dbc31157" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ce36b25c25d31e1a499d42dbc31157</link><br /><link linkTarget="URL" linkTerm="https://doi.org/10.1210/clinem/dgab569" linkWindow="_blank">https://doi.org/10.1210/clinem/dgab569</link> )
Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => OPEN )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....b2ce36b25c25d31e1a499d42dbc31157 )
RecordInfo Array ( [BibEntity] => Array ( [Languages] => Array ( [0] => Array ( [Text] => English ) ) [PhysicalDescription] => Array ( [Pagination] => Array ( [PageCount] => 11 [StartPage] => 3515 ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => Oncology [Type] => general ) [1] => Array ( [SubjectFull] => Male [Type] => general ) [2] => Array ( [SubjectFull] => Databases, Factual [Type] => general ) [3] => Array ( [SubjectFull] => Endocrinology, Diabetes and Metabolism [Type] => general ) [4] => Array ( [SubjectFull] => Neuroendocrine Tumors/diagnosis [Type] => general ) [5] => Array ( [SubjectFull] => Clinical Biochemistry [Type] => general ) [6] => Array ( [SubjectFull] => Disease [Type] => general ) [7] => Array ( [SubjectFull] => Biochemistry [Type] => general ) [8] => Array ( [SubjectFull] => multiple endocrine neoplasia type 1 [Type] => general ) [9] => Array ( [SubjectFull] => Endocrinology [Type] => general ) [10] => Array ( [SubjectFull] => Medicine [Type] => general ) [11] => Array ( [SubjectFull] => Age of Onset [Type] => general ) [12] => Array ( [SubjectFull] => Multiple endocrine neoplasia [Type] => general ) [13] => Array ( [SubjectFull] => Child [Type] => general ) [14] => Array ( [SubjectFull] => Early Detection of Cancer [Type] => general ) [15] => Array ( [SubjectFull] => Netherlands [Type] => general ) [16] => Array ( [SubjectFull] => ENDOCRINE NEOPLASIA TYPE-1 [Type] => general ) [17] => Array ( [SubjectFull] => education.field_of_study [Type] => general ) [18] => Array ( [SubjectFull] => INTERVAL-CENSORED-DATA [Type] => general ) [19] => Array ( [SubjectFull] => Middle Aged [Type] => general ) [20] => Array ( [SubjectFull] => Prognosis [Type] => general ) [21] => Array ( [SubjectFull] => Penetrance [Type] => general ) [22] => Array ( [SubjectFull] => age-related penetrance [Type] => general ) [23] => Array ( [SubjectFull] => Tumor Burden [Type] => general ) [24] => Array ( [SubjectFull] => Survival Rate [Type] => general ) [25] => Array ( [SubjectFull] => Neuroendocrine Tumors [Type] => general ) [26] => Array ( [SubjectFull] => Child, Preschool [Type] => general ) [27] => Array ( [SubjectFull] => Cohort [Type] => general ) [28] => Array ( [SubjectFull] => surveillance [Type] => general ) [29] => Array ( [SubjectFull] => Female [Type] => general ) [30] => Array ( [SubjectFull] => Rare cancers Radboud Institute for Health Sciences [Radboudumc 9] [Type] => general ) [31] => Array ( [SubjectFull] => Adult [Type] => general ) [32] => Array ( [SubjectFull] => Diagnostic Imaging [Type] => general ) [33] => Array ( [SubjectFull] => medicine.medical_specialty [Type] => general ) [34] => Array ( [SubjectFull] => pancreatic NET [Type] => general ) [35] => Array ( [SubjectFull] => Adolescent [Type] => general ) [36] => Array ( [SubjectFull] => Population [Type] => general ) [37] => Array ( [SubjectFull] => Context (language use) [Type] => general ) [38] => Array ( [SubjectFull] => Netherlands/epidemiology [Type] => general ) [39] => Array ( [SubjectFull] => Databases [Type] => general ) [40] => Array ( [SubjectFull] => Young Adult [Type] => general ) [41] => Array ( [SubjectFull] => SDG 3 - Good Health and Well-being [Type] => general ) [42] => Array ( [SubjectFull] => Internal medicine [Type] => general ) [43] => Array ( [SubjectFull] => Humans [Type] => general ) [44] => Array ( [SubjectFull] => MEN1 [Type] => general ) [45] => Array ( [SubjectFull] => Pancreatic Neoplasms/diagnosis [Type] => general ) [46] => Array ( [SubjectFull] => education [Type] => general ) [47] => Array ( [SubjectFull] => Preschool [Type] => general ) [48] => Array ( [SubjectFull] => Survival analysis [Type] => general ) [49] => Array ( [SubjectFull] => Factual [Type] => general ) [50] => Array ( [SubjectFull] => Aged [Type] => general ) [51] => Array ( [SubjectFull] => Retrospective Studies [Type] => general ) [52] => Array ( [SubjectFull] => business.industry [Type] => general ) [53] => Array ( [SubjectFull] => Biochemistry (medical) [Type] => general ) [54] => Array ( [SubjectFull] => medicine.disease [Type] => general ) [55] => Array ( [SubjectFull] => Pancreatic Neoplasms [Type] => general ) [56] => Array ( [SubjectFull] => Multiple Endocrine Neoplasia Type 1/physiopathology [Type] => general ) [57] => Array ( [SubjectFull] => Early Detection of Cancer/methods [Type] => general ) [58] => Array ( [SubjectFull] => business [Type] => general ) [59] => Array ( [SubjectFull] => Follow-Up Studies [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Olaf M. Dekkers ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Gerlof D. Valk ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Wouter T Zandee ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => M. R. Vriens ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Wouter W. de Herder ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Bas Havekes ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Mirthe J Klein Haneveld ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Annenienke C van de Ven ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Peter H. Bisschop ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Carolina R.C. Pieterman ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Madeleine L. Drent ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Annemarie A Verrijn Stuart ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Mark J C van Treijen ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Rachel S van Leeuwaarde ) ) ) [14] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Internal Medicine ) ) ) [15] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Internal medicine ) ) ) [16] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep ) ) ) [17] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Amsterdam Gastroenterology Endocrinology Metabolism ) ) ) [18] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Interne Geneeskunde ) ) ) [19] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => MUMC+: MA Endocrinologie (9) ) ) ) [20] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => RS: NUTRIM - R1 - Obesity, diabetes and cardiovascular health ) ) ) [21] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Endocrinology ) ) ) [22] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => AMS - Ageing & Vitality ) ) ) [23] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => AMS - Musculoskeletal Health ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 12 [Type] => published [Y] => 2021 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-print [Value] => 0021972X ) [1] => Array ( [Type] => issn-locals [Value] => edsair ) [2] => Array ( [Type] => issn-locals [Value] => edsairFT ) ) [Numbering] => Array ( [0] => Array ( [Type] => volume [Value] => 106 ) [1] => Array ( [Type] => issue [Value] => 12 ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Journal of Clinical Endocrinology & Metabolism [Type] => main ) ) ) ) ) ) )
IllustrationInfo